BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36510593)

  • 1. Engineering probiotic-derived outer membrane vesicles as functional vaccine carriers to enhance immunity against SARS-CoV-2.
    Wo J; Lv ZY; Sun JN; Tang H; Qi N; Ye BC
    iScience; 2023 Jan; 26(1):105772. PubMed ID: 36510593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A "Plug-and-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-binding Domain.
    Feng R; Li GC; Jing HM; Liu C; Xue RY; Zou QM; Li HB
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35938846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of foreign antigens by engineered outer membrane vesicle vaccines.
    Chen DJ; Osterrieder N; Metzger SM; Buckles E; Doody AM; DeLisa MP; Putnam D
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3099-104. PubMed ID: 20133740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.
    Grandi A; Tomasi M; Ullah I; Bertelli C; Vanzo T; Accordini S; Gagliardi A; Zanella I; Benedet M; Corbellari R; Di Lascio G; Tamburini S; Caproni E; Croia L; Ravà M; Fumagalli V; Di Lucia P; Marotta D; Sala E; Iannacone M; Kumar P; Mothes W; Uchil PD; Cherepanov P; Bolognesi M; Pizzato M; Grandi G
    Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2.
    Thapa HB; Müller AM; Camilli A; Schild S
    Front Microbiol; 2021; 12():752739. PubMed ID: 34803974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.
    Grandi A; Tomasi M; Ullah I; Bertelli C; Vanzo T; Accordini S; Gagliardi A; Zanella I; Benedet M; Corbellari R; Lascio GD; Tamburini S; Caproni E; Croia L; Ravà M; Fumagalli V; Lucia PD; Marotta D; Sala E; Iannacone M; Kumar P; Mothes W; Uchil PD; Cherepanov P; Bolognesi M; Pizzato M; Grandi G
    Res Sq; 2023 May; ():. PubMed ID: 37292970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
    Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
    Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of
    Croia L; Boscato Sopetto G; Zanella I; Caproni E; Gagliardi A; Tamburini S; König E; Benedet M; Di Lascio G; Corbellari R; Grandi A; Tomasi M; Grandi G
    Membranes (Basel); 2023 Nov; 13(11):. PubMed ID: 37999368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2.
    Yang Z; Hua L; Yang M; Liu SQ; Shen J; Li W; Long Q; Bai H; Yang X; Ren Z; Zheng X; Sun W; Ye C; Li D; Zheng P; He J; Chen Y; Huang W; Peng X; Ma Y
    Nano Lett; 2021 Jul; 21(14):5920-5930. PubMed ID: 34279108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles.
    Rosenthal JA; Huang CJ; Doody AM; Leung T; Mineta K; Feng DD; Wayne EC; Nishimura N; Leifer C; DeLisa MP; Mendez S; Putnam D
    PLoS One; 2014; 9(11):e112802. PubMed ID: 25426709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.
    Fantappiè L; de Santis M; Chiarot E; Carboni F; Bensi G; Jousson O; Margarit I; Grandi G
    J Extracell Vesicles; 2014; 3():. PubMed ID: 25147647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology.
    Cheng K; Zhao R; Li Y; Qi Y; Wang Y; Zhang Y; Qin H; Qin Y; Chen L; Li C; Liang J; Li Y; Xu J; Han X; Anderson GJ; Shi J; Ren L; Zhao X; Nie G
    Nat Commun; 2021 Apr; 12(1):2041. PubMed ID: 33824314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
    Guo Y; He W; Mou H; Zhang L; Chang J; Peng S; Ojha A; Tavora R; Parcells MS; Luo G; Li W; Zhong G; Choe H; Farzan M; Quinlan BD
    mBio; 2021 May; 12(3):. PubMed ID: 33975938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust Immune Response Induced by
    Barbosa MMF; Kanno AI; Barazzone GC; Rodriguez D; Pancakova V; Trentini M; Faquim-Mauro EL; Freitas AP; Khouri MI; Lobo-Silva J; Goncalves VM; Schenkman RPF; Tanizaki MM; Boraschi D; Malley R; Farias LP; Leite LCC
    Int J Nanomedicine; 2021; 16():7153-7168. PubMed ID: 34712047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor.
    Wang S; Huang W; Li K; Yao Y; Yang X; Bai H; Sun W; Liu C; Ma Y
    Int J Nanomedicine; 2017; 12():6813-6825. PubMed ID: 28979120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach.
    Daleke-Schermerhorn MH; Felix T; Soprova Z; Ten Hagen-Jongman CM; Vikström D; Majlessi L; Beskers J; Follmann F; de Punder K; van der Wel NN; Baumgarten T; Pham TV; Piersma SR; Jiménez CR; van Ulsen P; de Gier JW; Leclerc C; Jong WS; Luirink J
    Appl Environ Microbiol; 2014 Sep; 80(18):5854-65. PubMed ID: 25038093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.